Keywords: GVK Biosciences, Onconova, Cancer drug development, Rigosertib, Ex-RAD, ON-013105

GVK Biosciences and Onconova in cancer drug development deal

Article | 09 January 2013

GVK Biosciences, a Hyderabad, India-based contract research and development organization, and privately-held US biopharma company Onconova Therapeutics have entered into ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in